Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:00 AM UTC
| NCT Number | NCT07301268 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-Wildtype |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | April 8, 2026 (Apr 8, 2026) |
As of July 13, 2026: Clinical trial NCT07301268 is currently recruiting participants. This clinical trial study for glioblastoma, idh-wildtype is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07301268 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07301268 was last updated Apr 8, 2026 (April 8, 2026). HelloStudys verifies this status automatically.